Spotlight on Subcutaneous Recombinant Interferon- -1a (Rebif ® ) in Relapsing-Remitting Multiple Sclerosis

Author： Murdoch David   Lyseng-Williamson Katherine A.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.19, Iss.5, 2005-01, pp. : 323-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Interferon- -1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By Paul L. McCormack   Lesley J. Scott  

BioDrugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 343-347

Adis International

Access to resources Recommend Favorite

Recombinant Interferon- -1a: A Review of its Therapeutic Efficacy in Relapsing-Remitting Multiple Sclerosis

By Wagstaff A.J.   Goa K.L.  

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 471-494

Adis International

Access to resources Recommend Favorite

Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

By Simpson D.   Noble S.   Perry C.  

BioDrugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Relapsing-Remitting Multiple Sclerosis: What is the Potential for Combination Therapy?

By Mäurer M.   Rieckmann P.  

BioDrugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 149-158

Adis International

Access to resources Recommend Favorite

Appropriate Use of Interferon Beta-1a in Multiple Sclerosis

By Jacobs L.   Brownscheidle C.M.  

BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite